Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07413991 · ClinicalTrials.gov registry record · NA
Expressive Writing Program Among Young Adults With Blood Cancer
A NA study of Hematologic Malignancy, sponsored by Blood Cancer United.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07413991 is a NA study of Hematologic Malignancy that is active but no longer recruiting, run by Blood Cancer United. The registered enrollment target is 100 participants, below the 226-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07413991, a NA study of Hematologic Malignancy, is active but no longer recruiting, sponsored by Blood Cancer United.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will * Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.
Conditions Studied
Interventions
- BEHAVIORAL Expressive Writing Workshop
Study Locations (1)
District of Columbia
- Blood Cancer United - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07413991
The ClinicalTrials.gov registry entry for NCT07413991 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 226-participant average among 48 other Hematologic Malignancy trials with a reported enrollment target (56% lower). The listed sponsor is Blood Cancer United, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematologic Malignancy appearing as the primary indexed condition, and to 1 intervention - of which Expressive Writing Workshop is the first listed.
NCT07413991 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT07413991 about?
NCT07413991 is a clinical study titled "Expressive Writing Program Among Young Adults With Blood Cancer". The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will * Take part in an online expressive writing workshop for ...
What is the current status of trial NCT07413991?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-02-01. Estimated completion is 2026-09-30.
What conditions does trial NCT07413991 study?
This clinical trial studies the following conditions: Hematologic Malignancy.
What interventions are being tested in trial NCT07413991?
The interventions under investigation include: Expressive Writing Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT07413991?
This trial is sponsored by Blood Cancer United, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07413991 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Malignancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
RECRUITING · NA
-
Implementation of an Oral Chemotherapy Adherence Intervention
RECRUITING · NA
-
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
RECRUITING · NA
-
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
RECRUITING · NA
-
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.